Researchers are learning how extrachromosomal DNA (ecDNA) can drive tumor growth, treatment resistance, and cancer evolution. These discoveries may help identify new strategies for targeting some of the most aggressive cancers. https://t.co/QNTor07KJW #AACRStories
Early detection can make a difference. For those at high risk, liver cancer screening may help identify disease before symptoms appear and when more treatment options may be available. Learn more: https://t.co/MLOj0PpEWO
This week in cancer news: Adolescents who develop colorectal cancer are often diagnosed at an advanced stage; 1 in 8 cancer cases globally is linked to infections; and more. https://t.co/eYwUH8CUrn
The @AACR#Runners4Research team is lacing up their shoes for @Philly_Marathon Weekend this November to support lifesaving cancer research. Help the team reach its fundraising goal with a donation: https://t.co/iu7jblgiCk
From first-in-human studies to precision oncology, Lillian L. Siu, MD, has played a pivotal role in advancing cancer drug development. Learn more about her contributions to bringing new therapies to patients. https://t.co/uqHoz6zOAC
Hepatitis B and hepatitis C are leading causes of liver cancer worldwide. Because these infections can silently damage the liver over time, awareness, testing, vaccination against hepatitis B, and access to treatment are critical tools for prevention. https://t.co/i8bHZ54Nj3
What is cancer research? Learn about the cycle of cancer research and the continuum of cancer science, including basic, translational, clinical, and population research: https://t.co/PazDoOSgCd
Up to 18 percent of all pediatric cancer cases are attributed to pathogenic or likely pathogenic germline variants in cancer predisposition genes. Read more in the @AACR Pediatric Cancer Progress Report: https://t.co/X0JUAliuzM
#DYK? Kidney cancer is among the 10 most common cancers in the United States. Learning about risk factors, symptoms, diagnosis, and treatment options can help inform care decisions. https://t.co/ECLtkvbkLT
Returning to exercise after cancer treatment can take time. Staying active can improve strength, reduce fatigue, and support overall well-being, but it's important to work with your care team to find a safe, appropriate approach for you. https://t.co/5W4iY1dsr6
Exercise is increasingly recognized as an important part of cancer prevention and survivorship. Learn how physical activity can support patients throughout the cancer continuum. https://t.co/rLtTOmA3Ez
The fall issue of @CancerTodayMag covers breast cancer survivor Debbie Denardi’s efforts to educate others about inherited cancer risk, different kinds of activity-based groups for cancer survivors, and more. Read about the issue on the #AACRBlog: https://t.co/vhDElnbyAn
@AACR@US_FDA Mismatch repair-deficient colon cancer is a distinct subtype of colon cancer known to be more responsive to immunotherapy. Learn more about prevention, screening, and treatment options for colon cancer: https://t.co/dBxN931v2t
Learn more about Donor-Advised Funds and how you can establish one to support your charitable goals, including advancing lifesaving cancer science and medicine: https://t.co/Pms7vXpL2z #CancerResearchSavesLives
Today is DAF Day, a nationwide celebration of generosity through Donor-Advised Funds. If you have a Donor-Advised Fund, you can give easily and have it counted toward DAF Day's impact by selecting "Donor-Advised Fund" to complete your gift: https://t.co/RF3MyYtEQU
According to a study published in @CD_AACR, the typical age cutoffs used to guide germline genetic screening in patients with cancer may fail to detect the majority of inherited genetic risk factors for cancer. Read more: https://t.co/imAAdjYhfP
The @AACR#Runners4Research team is running to save lives on @Philly_Marathon Weekend this November. Your donation to the team supports lifesaving cancer research: https://t.co/CvkeEzDvV2
Everyone's experience with cancer is deeply personal. Whether you're a patient, survivor, caregiver, or loved one, your story can offer hope, inspiration, and strength to others facing similar challenges. Share your story today: https://t.co/Tj82W78cvS
The @AACR Scientist↔Survivor Program® creates enduring partnerships among cancer survivors, advocates, and scientists. By strengthening collaboration among these key constituencies, #AACRSSP accelerates progress in cancer science and medicine. Learn more: https://t.co/kLNKDh5Eod